Mitsubishi UFJ Trust & Banking Corp
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1462160
TOKYO, M0
Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$245,870
New position
Shares Held
24,587
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#190
of 316 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $73,921,281 across 21 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
104,854 | $17,672,092 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
484,342 | $16,409,506 | |
| 3 | ZTS |
Zoetis Inc.
|
213,961 | $15,375,236 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
26,181 | $14,185,650 | |
| 5 | VTRS |
Viatris Inc
|
169,266 | $2,687,944 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
56,705 | $1,395,510 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
211,124 | $1,040,841 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
21,928 | $793,793 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,870 | 24,587 | Shares | Defined | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||